Key Points
- CEO Adam Levy sold 4,000 shares on November 6 at an average of $2.52 for $10,080, leaving him with 367,692 shares (a 1.08% decline in his ownership).
- NexGel shares were trading up ~3.8% (opened $2.48) but the company missed quarterly expectations (EPS -$0.09 vs. -$0.07 est., revenue $2.88M vs. $3.08M), has negative profitability and a small market cap (~$20.2M), and carries an average analyst rating of "Sell."
- Institutional ownership is very low at about 2.21%, though a few small hedge funds and managers have recently initiated or increased minor positions.
NexGel, Inc. (NASDAQ:NXGL - Get Free Report) CEO Adam Levy sold 4,000 shares of the business's stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $2.52, for a total value of $10,080.00. Following the completion of the transaction, the chief executive officer directly owned 367,692 shares in the company, valued at approximately $926,583.84. This represents a 1.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
NexGel Trading Up 3.8%
NXGL stock opened at $2.48 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.74 and a quick ratio of 0.98. NexGel, Inc. has a 1-year low of $2.10 and a 1-year high of $5.10. The business has a 50 day simple moving average of $2.47 and a two-hundred day simple moving average of $2.46. The company has a market capitalization of $20.19 million, a price-to-earnings ratio of -6.20 and a beta of 0.57.
NexGel (NASDAQ:NXGL - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.02). NexGel had a negative return on equity of 49.37% and a negative net margin of 25.02%.The company had revenue of $2.88 million during the quarter, compared to analysts' expectations of $3.08 million.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of NexGel in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of "Sell".
Get Our Latest Research Report on NXGL
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Malaga Cove Capital LLC bought a new stake in NexGel in the second quarter worth $27,000. XTX Topco Ltd bought a new position in NexGel during the first quarter valued at $30,000. Flaharty Asset Management LLC purchased a new position in shares of NexGel in the 1st quarter worth $57,000. IFP Advisors Inc increased its holdings in shares of NexGel by 100.0% in the 1st quarter. IFP Advisors Inc now owns 22,000 shares of the company's stock worth $66,000 after buying an additional 11,000 shares during the last quarter. Finally, Essex Investment Management Co. LLC purchased a new stake in shares of NexGel during the 1st quarter valued at about $115,000. 2.21% of the stock is currently owned by institutional investors.
About NexGel
(
Get Free Report)
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
